Chronic Myeloproliferative Disorders Completed Phase 3 Trials for Erythropoietin (DB00016)

IndicationStatusPhase
DBCOND0028462 (Chronic Myeloproliferative Disorders)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00003600Epoetin Alfa in Treating Anemia in Patients Who Are Receiving ChemotherapySupportive Care